| 1 |
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
53
62
|
Cantara S...Pacini F
|
20130073 |
2010 |
| 2 |
BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?
53
62
|
Cameselle-Teijeiro J...Sobrinho-Simoes M
|
19269016 |
2009 |
| 3 |
Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
53
62
|
Patel MR...Zanation AM
|
19528408 |
2009 |
| 4 |
Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
53
62
|
Tabriz HM...Tavangar SM
|
18996649 |
2009 |
| 5 |
Differential expression of CK 19 in follicular adenoma, well-differentiated tumour of uncertain malignant potential (WDT-UMP) and follicular variant of papillary carcinoma.
53
62
|
Bukhari U...Kehar SI
|
19213370 |
2009 |
| 6 |
TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency.
53
62
|
Krause K...Fuhrer D
|
18198227 |
2008 |
| 7 |
Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
53
62
|
Matesa N...Kusic Z
|
17397496 |
2007 |
| 8 |
Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma.
53
62
|
Scognamiglio T...Chen YT
|
17050067 |
2006 |
| 9 |
Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas.
53
62
|
Ulisse S...D'Armiento M
|
16928445 |
2006 |
| 10 |
Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
53
62
|
Cho Mar K...Tateyama H
|
16722928 |
2006 |
| 11 |
The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
53
62
|
Savin S...Havelka M
|
16614712 |
2006 |
| 12 |
Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma.
53
62
|
Nakamura N...Lloyd RV
|
17308358 |
2006 |
| 13 |
RET and p53 expression in thyroid follicular adenoma: a study of 52 cases with 14 years follow-up.
53
62
|
Othman NH...Madhavan M
|
17191391 |
2005 |
| 14 |
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
53
62
|
Trovisco V...Sobrinho-Simoes M
|
15902486 |
2005 |
| 15 |
Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
53
62
|
de Souza Meyer EL...Maia AL
|
15943828 |
2005 |
| 16 |
Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma.
53
62
|
Mai KT...Stinson WA
|
15735853 |
2005 |
| 17 |
Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
53
62
|
Maruta J...Noguchi S
|
15540177 |
2004 |
| 18 |
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
53
62
|
Mehrotra P...Lennard TW
|
15500653 |
2004 |
| 19 |
Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study.
53
62
|
Kim SJ...Yoo MH
|
15483349 |
2004 |
| 20 |
Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
53
62
|
Omar E...Othman NH
|
15203751 |
2004 |
| 21 |
High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.
53
62
|
Takano T...Amino N
|
15083192 |
2004 |
| 22 |
S100A4 expression is an early event of papillary carcinoma of the thyroid.
53
62
|
Ito Y...Miyauchi A
|
15713996 |
2004 |
| 23 |
Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
53
62
|
Maruta J...Noguchi S
|
14718282 |
2004 |
| 24 |
Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma.
53
62
|
Cameron BR...Berean KW
|
14974863 |
2003 |
| 25 |
Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
53
62
|
Gustafson KS...Baloch ZW
|
12931546 |
2003 |
| 26 |
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
53
62
|
Xu X...Prinz RA
|
12907632 |
2003 |
| 27 |
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
53
62
|
Soares P...Sobrinho-Simoes M
|
12881714 |
2003 |
| 28 |
Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type.
53
62
|
Inaba M...Osamura RY
|
12608895 |
2003 |
| 29 |
Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
53
62
|
Jakubiak-Wielganowicz M...Kordek R
|
14575419 |
2003 |
| 30 |
Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
53
62
|
Martins L...Kimura ET
|
12364477 |
2002 |
| 31 |
Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents.
53
62
|
Niedziela M...Korman E
|
12213909 |
2002 |
| 32 |
Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues.
53
62
|
Porra V...Rousset B
|
11932304 |
2002 |
| 33 |
Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid.
53
62
|
Erkilic S...Kocer NE
|
12446919 |
2002 |
| 34 |
uPA receptor expression in benign and malignant thyroid tumors.
53
62
|
Kim SJ...Noguchi S
|
12017319 |
2002 |
| 35 |
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
53
62
|
Sahoo S...DeLellis RA
|
11710686 |
2001 |
| 36 |
Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma.
53
62
|
Saggiorato E...Orlandi F
|
11701669 |
2001 |
| 37 |
Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.
53
62
|
Mai KT...Odell PF
|
11454041 |
2001 |
| 38 |
Ret oncogene protein expression in papillary thyroid carcinoma and related lesions.
53
62
|
Mai KT...Odell PF
|
11504372 |
2001 |
| 39 |
Clinical significance of E-cadherin expression in thyroid neoplasms.
53
62
|
Naito A...Kobayashi S
|
11276021 |
2001 |
| 40 |
Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
53
62
|
Nascimento MC...Medeiros-Neto G
|
11740048 |
2001 |
| 41 |
Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
53
62
|
Nasser SM...Faquin WC
|
11038428 |
2000 |
| 42 |
Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.
53
62
|
Huang SH...Wang SM
|
10595458 |
1999 |
| 43 |
Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
53
62
|
Hocevar M...Auersperg M
|
9870733 |
1998 |
| 44 |
The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis.
53
62
|
Wang S...Khan A
|
9824112 |
1998 |
| 45 |
c-Met expression of thyroid tissue with special reference to papillary carcinoma.
53
62
|
Oyama T...Nakajima T
|
9788259 |
1998 |
| 46 |
Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters.
53
62
|
Lam AK...Livolsi VA
|
9635675 |
1998 |
| 47 |
Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells.
53
62
|
Gu J...Noguchi S
|
9589486 |
1998 |
| 48 |
Integrins in thyroid tissue: upregulation of alpha2beta1 in anaplastic thyroid carcinoma.
53
62
|
Dahlman T...Westermark K
|
9461325 |
1998 |
| 49 |
Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases.
53
62
|
LaGuette J...Rosai J
|
9236830 |
1997 |
| 50 |
Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications.
53
62
|
Okamoto T...Obara T
|
9152633 |
1997 |
